Dataset Groups approved Phase II Immunotherapy Trial SG-2024 This dataset has been reviewed and approved! Data and Resources Unnamed resource Explore More information Go to resource Additional Info Field Value Disease Area Neoplasms Organism Homo sapiens Data Access Type Open Access Trial Phase Phase II ClinicalTrials.gov ID NCT04512345 Intervention Type Drug Primary Endpoint Test Recruitment Status Recruiting Sample Size 2050 Source Version Author Author Email Maintainer Maintainer Email